LXRX news

Latest 1 stories · newest Aug 6, 2026

LXRX

Lexicon Submits Clinical Results in HCM Study, Updates ZYNQUISTA Data

Lexicon Pharmaceuticals announces completed enrollment for SONATA-HCM with Q1 2027 topline data expected; NDA resubmission for ZYNQUISTA in Type 1 diabetes nearing completion.

Guidance|Regulatory Aug 6, 2026 sentiment +0.15 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same LXRX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/LXRX/newsSTART FREE